PHARM 1 EXAM #3 Flashcards

1
Q

Neurotransmitters (NTs) + Receptors + Enzymes in Sympathetic vs Parasympathetic Nervous Systems

A

Sympathetic Nervous System (SNS)
NTs: Norepinephrine, Epinephrine, Dopamine
Receptors: a1, a2, b1, b2
Enzymes: Monoamine Oxidase (MAO), Catechol-O-Methyltransferase (COMT)

Parasympathetic Nervous System (PNS)
NTs: Acetylcholine (ACh)
Receptors: muscarnic, nicotinic
Enzymes: Acetylcholinesterase (ACh-ase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Alzheimer’s Disease (AD)?

A

Alzheimer’s disease (AD) is characterized by progressive memory loss, impaired thinking, personality changes (neuropsychiatric symptoms), and inability to perform routine tasks of daily living.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of Alzheimer’s Disease

A

— Memory loss
— Confusion
— Inability to communicate
— Aggressive behavior
— Depression
— Psychoses
— Progression to loss of memory, logical thinking, and judgment; time disorientation; personality changes; hyperactivity; tendency to wander; inability to express oneself; and later hostility, paranoia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of Alzheimer’s disease

A

— Incurable dementia illness
— Chronic, progressive neurodegenerative conditions
— Marked cognitive dysfunction
— Onset usually occurs between ages 45 and 65 years, risk increases after 65.
— Neuritic plaques form (outside of neurons)
— Neurofibrillary tangles are in neurons.
— Cholinergic neurotransmitter abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which are the most common degenerative diseases of nerves?

A

1st = Alzheimer’s Disease
2nd = Parkinson’s Disease (PD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Summarize the pathophysiology of Parkinsonism

A

Parkinson’s:
– Chronic neurologic disorder
– Imbalance of the neurotransmitters dopamine (DA) and acetylcholine (ACh)
– Marked by degeneration of neurons of the
extrapyramidal motor tract
– Reason for the degeneration of neurons is
unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of Parkinsonism

A

– Tremors of head, neck, and limbs
– Rigidity (increased muscle tone)
– Bradykinesia (slow movement)
– Postural changes: head and chest thrown forward
– Shuffling walk
– Lack of facial expression
– Pill-rolling motion of hands
– Common non-motor symptoms: depression,
psychosis, dementia, sleep disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Differences between depression vs. psychosis

A

Depression — lack of motivation, disinterest; “blah” feeling..don’t care
Psychosis — lack of being in touch with reality; hallucinations, paranoia present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the treatments (Tx) regimens for Parkinsonism?

A

– Anticholinergics
– Dopaminergics
– Dopamine agonists
– MAO-B inhibitors
– COMT inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Action of Anticholinergics in treatment of Parkinson’s Disease

A

oldest drugs used as treatment
— Inhibits release of acetylcholine (ACh); parasympatholytic
— Blocks cholinergic receptors in order to push the ACh influence down in CNS, which helps to restore the balance of ACh + Dopamine in the body
— Reduce the rigidity and some of the tremors characteristic of parkinsonism
Minimal effect on bradykinesia
— Used to treat drug-induced parkinsonism, or pseudoparkinsonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NON-DRUG Tx for Mirgraines

A

Adequate sleep
Exercise
Avoiding triggers
Once headache begins
Quiet, dark room with ice pack to neck
Supplements
Riboflavin (Vitamin B2)
Coenzyme Q-10
Feverfew
Butterbur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Interventions for taking Anticholinergic Drugs

A

— Counsel patients who take an anticholinergic to have routine eye exams because anticholinergics are contraindicated in patients with glaucoma.
— Encourage patients to relieve a dry mouth with hard candy, ice chips, or sugarless gum.
— Monitor urine output (I&Os) for early detection of urinary retention.
— Increase fluid intake, fiber, and exercise to avoid constipation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antiparkinsonism Drugs RN Interventions

A

— Monitor for orthostatic hypotension.
— Administer drug with low-protein foods.
— Avoid vitamin B6, alcohol, other depressants.
— Do not abruptly discontinue
— Warn of harmless brown discoloration of urine and sweat.
— Assess for suicidal tendencies.
— Assess symptom status and “on-off” phenomenon.
— Monitor blood cell counts, liver and kidney function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Correlation with protein-rich foods + Medication + Parkinson’s Disease

A

— Food does slow drug absorption.
— High-protein foods interfere with drug transport to CNS.
— Foods high in vitamin B6 include lima, navy, kidney beans; cereals.
— Vitamin B6 inhibits conversion of levodopa to dopamine.
— A conservative amount of vitamin B6 is needed to prevent vitamin B6 deficiency (peripheral neuritis, muscle weakness).
— want low protein foods with PD medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Actions of Dopaminergics in treatment of Parkinson’s Disease

A

— Converts to dopamine
— A mimetic that mimics dopamine and becomes dopamine in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Centrally Acting Anticholinergics: Benztropine (Cogentin) + Trihexyphenidyl (Artane)

A

— Reduce tremor and possibly rigidity
No reduction of bradykinesia
— Less effective than levodopa or the dopamine agonists but better tolerated
— Used as second-line therapy for tremor
— Most appropriate for younger patients with mild symptoms
— Avoided in the elderly, who are intolerant of CNS side effects (for example, sedation, confusion, delusions, hallucinations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Action of Dopamine Agonists in treatment of Parkinson’s Disease + Drugs

A

— Converted to dopamine and stimulates receptors to increase mobility
E.g. Carbidopa-levodopa (Sinemet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Advantages of combining Carbidopa/Levodopa

A

More dopamine reaches the basal ganglia and that smaller doses of levodopa are required to achieve the desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Contraindications to Dopaminergic therapy (carbidopa/levodopa (Sinemet))

A

— Narrow-angle glaucoma; severe cardiac, renal, hepatic disease; and suspicious skin lesions (activates malignant melanoma).
— Has a short half-life and must be taken 3-4 times per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Side effects of Dopaminergics In Antiparkinsonism drugs

A

— Fatigue, insomnia
— Dry mouth
— Blurred vision
— Orthostatic hypotension, palpitations, dysrhythmias
— Urinary retention
— GI disturbance: nausea, vomiting
— Dyskinesia, psychosis, severe depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drug interaction with Carbidopa-levodopa (Sinemet) in Dopaminergics

A

Decrease levodopa effect with:
— Anticholinergics
— Phenytoin
— Tricyclic antidepressants
— MAO inhibitors
— Benzodiazepines (works in CNS)
— Phenothiazines (works CNS)
— Vitamin B6

Because PD patients have too much ACh, there will be an imbalance of ACh + dopamine levels r/t dopamine becoming less effective if taken concurrently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Side effects for Anticholinergics

A

Dizziness, drowsiness, anxiety, headache
Insomnia, paresthesia, restlessness
Blurred vision, ocular hypertension
Weakness, dry mouth, GI distress
Anhidrosis, urinary retention

”Can’t see, can’t spit, can’t pee, can’t sht!”*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Action of MAO-B Inhibitors in treatment of Parkinson’s Disease

A

MAO-I = Monoamine Oxidase B Inhibitors

— Inhibit MAO-B enzyme that interferes with dopamine
— MAO = enzyme that breaks down NTs in the peripheral nervous system (PNS)
— MAO-B = enzyme that breaks down dopamine, therefore if we inhibit the enzyme —> an increase availability of dopamine in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

COMT inhibitors in the treatment of Parkinson

A

— Inhibit COMT enzyme that inactivates dopamine
— By stopping the breakdown of dopamine in the CNS + peripheral[P]NS in order to improve the effects of dopamine bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Side Effects for MAO-Is Selegiline + Parkinson’s Disease

A

— Dizziness, headache, nausea, dry mouth
— Orthostatic hypotension, hypertension
— Impulse control disorder, suicidal ideation
— Not as popular, but an option

_Interaction: foods high in tyramine can cause hypertensive crisis; hard to manage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Side Effects for COMT-Inhibitor + Parkinson’s Disease

A

COMT-I = Catechol-O-Methyltransferase Inhibitors

Drug: Tolcapone

— Dizziness, drowsiness, headache
— GI distress, excess dreams
— Insomnia, sudden sleep onset
— Orthostatic hypotension
— Impulse control disorder
— Hepatic dysfunction

27
Q

Other than dyskinesia, name the non-motor symptoms that arise in patients with Parkinson’s Disease

A

— Depression
— Psychosis and dementia
— Sleep disturbances
90% of patients develop these nonmotor symptoms

28
Q

What are some non-pharmacological treatments for Parkinson’s Disease?

A

— Exercise
— Balanced diet
— Support group

29
Q

Compare the side effects of various anti-Parkinsonism drugs

A
30
Q

Combination Preparation differences between Sinemet + Stalevo

A

levodopa/carbidopa (Sinemet)
— Carbidopa has no therapeutic effects of its own, but makes levodopa more available to the CNS, allowing the dosage of levodopa to be reduced by about 75%

** By combining carbidopa with levodopa, carbidopa can inhibit the enzyme decarboxylase in the periphery, thereby allowing more levodopa to reach the brain.**

levodopa/carbidopa/entacapone (Stalevo)
— Entacapone (Comtan) prolongs plasma level of levidopa/carbidopa, so if the effect of Simemet is wearing off entacapone can be added

31
Q

Contraindications of MAO-Is + Parkinson’s

A

Can cause a hypertensive crisis when given within 2 weeks of levodopa

32
Q

Apply the nursing process to anticholinergics, dopaminergics, and acetylcholinesterase
inhibitors

A
33
Q

What is the contraindications when having a high-protein diet while taking Antiparkinson’s drugs?

A

— A high protein diet impairs levodopa absorption and transport across BBB
— High protein meal can trigger an “off” episode, where it appears a patient is “off” their meds, but they aren’t

34
Q

Differentiate the phases of Alzheimer’s disease with corresponding symptoms

A
35
Q

Side Effects + Adverse Rxns of Rivastigmine (Exelon)

A

Drug = Acetylcholinesterase Inhibitors/Cholinesterase Inhibitor
Side effects:
— Anorexia, nausea, vomiting, diarrhea, constipation, abdominal pain, GI bleeding, dizziness, depression, peripheral edema, dry mouth, dehydration, restless legs syndrome, nystagmus

Adverse reactions
— Seizures, bradycardia, orthostatic hypotension, cataracts, myocardial infarction, heart failure

36
Q

Compare the side effects/adverse effects of acetylcholinesterase inhibitors that are used to
treat Alzheimer’s disease

A
37
Q

Contrast the pathophysiology of myasthenia gravis and multiple sclerosis

A
38
Q

Discuss the drug group used to treat myasthenia gravis

A
39
Q

Discuss the drug group used to treat multiple sclerosis

A

— Immunomodulators: 1st-line Tx; slows disease progression and prevents relapses
— Immunosuppressants
— Sphingosine 1-phosphate receptor modulator (for worsening)
— Monoclonal antibody (made in lab + specific to d/o)
— Corticosteroids: reduces edema and acute inflammation

40
Q

Immunomodulators

A

Administered by self-injection (IM, SubQ)
— Interferon beta (Avonex, Rebif); has flulike S/Sx
— Glatiramer acetate (Copaxone): gets severe chest pain, but WILL go away

IV infusion
— Natalizumab (Tysabri)

41
Q

Differentiate between the muscle relaxants used for spasticity and those used for muscle
spasms

A

Spasticity
— tightening of muscle b/c of MS, stroke, TBI, SCI , trauma in nervous system causing this (neurologic impairment/disorder)
Meds: Baclofen (Lioresal); Tizanidine (Zanaflex)

Muscle spasms
— pull your back and muscle tightens up d/t trauma, injury, overuse
Meds: Dantrolene Sodium (Dantrium)

42
Q

Skeletal Muscle Relaxants: Cyclobenzaprine (Flexaril)

A

Action
— Relax skeletal muscles

Use
— Relieves muscle spasms

Side Effects
—Anticholinergic effects (blurred vision, dry mouth, tachycardia, urine retention, constipation)
— Drowsiness, dizziness, headache, nervousness
— GI distress, unpleasant taste
— Dysrhythmias

contraindicated if patient has cardiovascular disorders, hyperthyroidism, hepatic impairment, or taking concurrent MAOIs. The nurse should note if there is a history of narrow-angle glaucoma or MG. Cyclobenzaprine is contraindicated with these health problems.

43
Q

RN Interventions for Cyclobenzaprine (Flexaril)

A

— Observe for CNS side effects = drowsiness
— Teach patient not to stop abruptly but taper off over 1 week.
— Teach patient to avoid alcohol and CNS depressants.
— Take with food.
—Monitor liver function
— Check vital signs.
— Advise patient not to drive
— No EtOH + smoking
— Inform patient that most centrally acting muscle relaxants are prescribed for no longer than 3 weeks (NOT LONG TERM)

44
Q

Determine the 2 ways of treating and affecting change in neuromuscular disorders

A

If your muscle is tight:
1) change in brain (centrally acting spasticity)
—Baclofen (Lioresal)
— Tizanidine (Zanaflex)

2) change at neuromuscular junction (direct acting spasticity)
— Dantrolene sodium (Dantrium)

45
Q

Apply the nursing process to drugs used to treat myasthenia gravis and muscle spasms

A
46
Q

Explain the pathophysiologic basis of five cardinal signs of inflammation

A
47
Q

Compare the action of various nonsteroidal antiinflammatory drugs (NSAIDs)

A
48
Q

Explain the use of disease-modifying antirheumatic drugs (DMARDs)

A
49
Q

Differentiate between the side effects and adverse reactions of NSAIDs and DMARDs

A
50
Q

Correlate the nursing processes associated with NSAIDs and corticosteroids, including
patient teaching

A
51
Q

Apply the nursing process to the patient taking DMARDs

A
52
Q

Compare the action of various antigout medications

A
53
Q

Differentiate between acute and chronic pain

A
54
Q

Compare indications for nonopioid and opioid analgesics

A
55
Q

Describe the serum therapeutic ranges of aspirin and acetaminophen. Identify the recommended
maximum daily dosage of acetaminophen

A
56
Q

Contrast the side effects of aspirin and opioids

A
57
Q

Explain the methadone treatment program

A
58
Q

Discuss nursing interventions and patient teaching related to nonopioid and opioid analgesics

A
59
Q

Apply the nursing process to the patient with patient-controlled analgesia (PCA)

A
60
Q

Discuss nursing implications and pharmacotherapy related to tension, cluster, and migraine headaches

A
61
Q

Drugs that treat cluster + migraine headaches

A

Analgesics
Aspirin (caffeine), acetaminophen
NSAIDs: ibuprofen, naproxen (Aleve)
Opioid analgesics
Meperidine (Demerol)
Butorphanol nasal spray (Stadol NS)
Ergot alkaloids
Dihydroergotamine mesylate (Migranal) – IV, IM, subQ, nasal
Selective serotonin1 receptor agonists [triptans]
Sumatriptan (Imitrex)
Zolmitriptan (Zomig)

62
Q

Discuss the differences between tension, cluster, migraine headaches

A

Tension —
Cluster — Severe unilateral nonthrobbing pain; usually located around the eye
Migraine — a neurovascular disorder involving dilation and inflammation of intracranial arteries.

63
Q

Side Effects for COMT-Inhibitor + Parkinson’s Disease

A